-
2
-
-
0028057250
-
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
-
(1994)
Blood
, vol.83
, pp. 435-445
-
-
Reff, M.E.1
Carner, K.2
Chambers, K.S.3
Chinn, P.C.4
Leonard, J.E.5
Raab, R.6
Newman, R.A.7
Hanna, N.8
Anderson, D.R.9
-
4
-
-
17144455839
-
IDEC-C2B8: Results of a Phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma
-
(1997)
J. Clin. Oncol.
, vol.15
, pp. 3266-3274
-
-
Maloney, D.G.1
Grillo-Lopez, A.J.2
Bodkin, D.J.3
White, C.A.4
Liles, T.M.5
Royston, I.6
Varns, C.7
Rosenberg, J.8
Levy, R.9
-
5
-
-
1842368507
-
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
-
(1997)
Blood
, vol.90
, pp. 2188-2195
-
-
Maloney, D.G.1
Grillo-Lopez, A.J.2
White, C.A.3
Bodkin, D.4
Schilder, R.J.5
Neidhart, J.A.6
Janakiraman, N.7
Foon, K.A.8
Liles, T.M.9
Dallaire, B.K.10
Wey, K.11
Royston, I.12
Davis, T.13
Levy, R.14
-
7
-
-
0032530342
-
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter Phase II study
-
(1998)
Blood
, vol.92
, pp. 1927-1932
-
-
Coiffier, B.1
Haioun, C.2
Ketterer, N.3
Engert, A.4
Tilly, H.5
Ma, D.6
Johnson, P.7
Lister, A.8
Feuring-Buske, M.9
Radford, J.A.10
Capdeville, R.11
Diehl, V.12
Reyes, F.13
-
10
-
-
0028174924
-
Overcoming TNF-α and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-α or drugs: The role of TNF-α mRNA downregulation in tumor cell sensitization
-
(1994)
J. Urol.
, vol.151
, pp. 1697-1702
-
-
Mizutani, Y.1
Bonavida, B.2
Nio, Y.3
Yoshida, O.4
-
16
-
-
0029558583
-
Bcl-2 family proteins: Regulators of chemoresistance in cancer
-
(1995)
Toxicol. Lett.
, vol.82-83
, pp. 155-158
-
-
Reed, J.C.1
-
17
-
-
0028098154
-
IgMs produced by two acquired immune deficiency syndrome lymphoma cell lines: Ig binding specificity and VH-gene putative somatic mutation analysis
-
published erratum appears in Blood, 84: 995, 1994
-
(1994)
Blood
, vol.83
, pp. 1067-1078
-
-
Ng, V.L.1
Hurt, M.H.2
Fein, C.L.3
Khayam-Bashi, F.4
Marsh, J.5
Nunes, W.M.6
McPhaul, L.W.7
Feigal, E.8
Nelson, P.9
Herndier, B.G.10
-
22
-
-
0023792919
-
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
-
(1988)
Cancer Res.
, vol.48
, pp. 4827-4833
-
-
Scudiero, D.A.1
Shoemaker, R.H.2
Paull, K.D.3
Monks, A.4
Tierney, S.5
Nofziger, T.H.6
Currens, M.J.7
Seniff, D.8
Boyd, M.R.9
-
23
-
-
7844225540
-
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
-
(1998)
Ann. Oncol.
, vol.9
, pp. 995-1001
-
-
Berinstein, N.L.1
Grillo-Lopez, A.J.2
White, C.A.3
Bence-Bruckler, I.4
Maloney, D.5
Czuczman, M.6
Green, D.7
Rosenberg, J.8
McLaughlin, P.9
Shen, D.10
-
29
-
-
0032915061
-
Preferential induction of TNF-α and IL-1β and inhibition of IL-10 secretion by human peripheral blood monocytes by synthetic aza-alkyl lysophospholipids
-
(1999)
Cell. Immunol.
, vol.193
, pp. 125-133
-
-
Gan, X.H.1
Bonavida, B.2
-
38
-
-
0031693706
-
Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody
-
(1998)
Jpn. J. Cancer Res.
, vol.89
, pp. 748-756
-
-
Taji, H.1
Kagami, Y.2
Okada, Y.3
Andou, M.4
Nishi, Y.5
Saito, H.6
Seto, M.7
Morishima, Y.8
-
39
-
-
0025224135
-
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1
-
(1990)
Science (Washington DC)
, vol.250
, pp. 830-832
-
-
Hsu, D.H.1
De Waal Malefyt, R.2
Fiorentino, D.F.3
Dang, M.N.4
Vieira, P.5
De Vries, J.6
Spits, H.7
Mosmann, T.R.8
Moore, K.W.9
-
50
-
-
0029115799
-
Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 22632-22638
-
-
Deans, J.P.1
Kalt, L.2
Ledbetter, J.A.3
Schieven, G.L.4
Bolen, J.B.5
Johnson, P.6
-
57
-
-
0030447760
-
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors
-
(1996)
Cancer Res.
, vol.56
, pp. 5499-5505
-
-
Voorzanger, N.1
Touitou, R.2
Garcia, E.3
Delecluse, H.J.4
Rousset, F.5
Joab, I.6
Favrot, M.C.7
Blay, J.Y.8
-
62
-
-
0032964570
-
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
-
(1999)
Ann. Oncol.
, vol.10
, pp. 433-440
-
-
Sarris, A.H.1
Kliche, K.O.2
Pethambaram, P.3
Preti, A.4
Tucker, S.5
Jackow, C.6
Messina, O.7
Pugh, W.8
Hagemeister, F.B.9
McLaughlin, P.10
Rodriguez, M.A.11
Romaguera, J.12
Fritsche, H.13
Witzig, T.14
Duvic, M.15
Andreeff, M.16
Cabanillas, F.17
-
63
-
-
0027434991
-
Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor
-
(1993)
Blood
, vol.82
, pp. 2169-2174
-
-
Blay, J.Y.1
Burdin, N.2
Rousset, F.3
Lenoir, G.4
Biron, P.5
Philip, T.6
Banchereau, J.7
Favrot, M.C.8
-
65
-
-
0030880984
-
Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: Identification and characterization of NF-κB binding sites in the regulatory region of the interleukin-10 gene
-
(1997)
Eur. J. Haematol.
, vol.59
, pp. 162-170
-
-
Mori, N.1
Prager, D.2
-
67
-
-
0024454762
-
Stress-resistance conferred by high level of bcl-2 α protein in human B lymphoblastoid cell
-
(1989)
Oncogene
, vol.4
, pp. 1331-1336
-
-
Tsujimoto, Y.1
-
68
-
-
0032055166
-
Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation
-
(1998)
Blood
, vol.91
, pp. 2272-2282
-
-
Domen, J.1
Gandy, K.L.2
Weissman, I.L.3
-
70
-
-
0027717968
-
Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
-
(1993)
Science (Washington DC)
, vol.262
, pp. 1274-1277
-
-
Kane, D.J.1
Sarafian, T.A.2
Anton, R.3
Hahn, H.4
Gralla, E.B.5
Valentine, J.S.6
Ord, T.7
Bredesen, D.E.8
-
71
-
-
0026781986
-
Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
-
(1992)
Cancer Res.
, vol.52
, pp. 5407-5411
-
-
Miyashita, T.1
Reed, J.C.2
-
73
-
-
0027523461
-
Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 6511-6519
-
-
Baffy, G.1
Miyashita, T.2
Williamson, J.R.3
Reed, J.C.4
-
78
-
-
0027943376
-
Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma
-
(1994)
Br. J. Haematol.
, vol.88
, pp. 770-777
-
-
Stasi, R.1
Zinzani, P.L.2
Galieni, P.3
Lauta, V.M.4
Damasio, E.5
Dispensa, E.6
Dammacco, F.7
Papa, G.8
Tura, S.9
-
80
-
-
0030477532
-
Serum interleukin-10 in acquired immunodeficiency syndrome lymphoma patients
-
Seroco-Hemoco Study Group
-
(1996)
Eur. Cytokine Netw.
, vol.7
, pp. 785-791
-
-
Edelman, L.1
Deveau, C.2
Raphael, M.3
Monchatre, E.4
Gabarre, J.5
Deville-Chabrol, A.6
Pialoux, G.7
Emilie, D.8
Joab, I.9
Galanaud, P.10
-
83
-
-
0031907428
-
Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
-
(1998)
Nat. Med.
, vol.4
, pp. 232-234
-
-
Jansen, B.1
Schlagbauer-Wadl, H.2
Brown, B.D.3
Bryan, R.N.4
Van Elsas, A.5
Muller, M.6
Wolff, K.7
Eichler, H.G.8
Pehamberger, H.9
-
84
-
-
0030888664
-
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
-
(1997)
Lancet
, vol.349
, pp. 1137-1141
-
-
Webb, A.1
Cunningham, D.2
Cotter, F.3
Clarke, P.A.4
Di Stefano, F.5
Ross, P.6
Corbo, M.7
Dziewanowska, Z.8
|